These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34032761)

  • 1. KIF4A as a novel prognostic biomarker in cholangiocarcinoma.
    Zhang DY; Ma SS; Sun WL; Lv XCH; Lu Z
    Medicine (Baltimore); 2021 May; 100(21):e26130. PubMed ID: 34032761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M expression and
    Liu Q; Lan T; Song Y; Cai J; Yu X; Chen W
    Aging (Albany NY); 2020 Nov; 12(21):21518-21543. PubMed ID: 33216732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice.
    Saengboonmee C; Obchoei S; Sawanyawisuth K; Wongkham S
    Expert Rev Anticancer Ther; 2023 May; 23(5):517-530. PubMed ID: 37052887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy.
    Nguyen CT; Caruso S; Maille P; Beaufrère A; Augustin J; Favre L; Pujals A; Boulagnon-Rombi C; Rhaiem R; Amaddeo G; di Tommaso L; Luciani A; Regnault H; Brustia R; Scatton O; Charlotte F; Brochériou I; Sommacale D; Soussan P; Leroy V; Laurent A; Le VK; Ta VT; Trinh HS; Tran TL; Gentien D; Rapinat A; Nault JC; Allaire M; Mulé S; Zucman-Rossi J; Pawlotsky JM; Tournigand C; Lafdil F; Paradis V; Calderaro J
    Clin Cancer Res; 2022 Feb; 28(3):540-551. PubMed ID: 34785581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
    Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
    J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma.
    Zhang B; Jin B; Wu X; Xing J; Liu X; Wan X; Xu H; Xu Y; Mao Y; Chen Q; Bai Y; Guan M; Du S
    Cancer Med; 2024 Aug; 13(16):e70135. PubMed ID: 39206584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
    Likhitrattanapisal S; Tipanee J; Janvilisri T
    Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma.
    Ong KH; Lai HY; Sun DP; Chen TJ; Huang SK; Tian YF; Chou CL; Shiue YL; Chan TC; Li CF; Kuo YH
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):75. PubMed ID: 37114547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on cholangiocarcinoma: potential impact of genomic studies on clinical management.
    Walter D; Hartmann S; Waidmann O
    Z Gastroenterol; 2017 Jun; 55(6):575-581. PubMed ID: 28376540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
    Chen Z; Yu M; Yan J; Guo L; Zhang B; Liu S; Lei J; Zhang W; Zhou B; Gao J; Yang Z; Li X; Zhou J; Fan J; Ye Q; Li H; Xu Y; Xiao Y
    Front Immunol; 2021; 12():647209. PubMed ID: 33841428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
    Wang Z; Du Y
    Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cholangiocarcinoma.
    Mertens JC; Ilyas SI; Gores GJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1454-1460. PubMed ID: 28844952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
    Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
    Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets.
    Huang QX; Cui JY; Ma H; Jia XM; Huang FL; Jiang LX
    Cancer Gene Ther; 2016; 23(2-3):48-53. PubMed ID: 26679756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
    Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
    Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
    Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
    EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma.
    Jiang XM; Li ZL; Li JL; Zheng WY; Li XH; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1242-1247. PubMed ID: 28387907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma.
    Tomlinson JL; Li B; Yang J; Loeuillard E; Stumpf HE; Kuipers H; Watkins R; Carlson DM; Willhite J; O'Brien DR; Graham RP; Chen X; Smoot RL; Dong H; Gores GJ; Ilyas SI
    J Hepatol; 2024 Jun; 80(6):892-903. PubMed ID: 38458319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic analysis the expression and clinical significance of CDRT15 in cholangiocarcinoma using TCGA database.
    Yu T; Zhang T; Zhao L; Li K; Li J; Yu A
    Medicine (Baltimore); 2023 Aug; 102(31):e34602. PubMed ID: 37543771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.